Clinical Trial Update: A Study of HX008 Plus Transcatheter Arterial Chemoembolization (TACE) in the First-Line Treatment of Subjects With Stage IV (M1c) Melanoma That is Metastatic to the Liver [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating HX008 in combination with Transcatheter Arterial Chemoembolization (TACE) as first-line treatment for stage IV (M1c) me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• HX008
• Transcatheter Arterial Chemoembolization (TACE)

Snippet

Sponsor: Taizhou Hanzhong biomedical co. LTD | Conditions: Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms | Phase 3 | Status: UNKNOWN